DX-8951f in Treating Patients With Metastatic Stomach Cancer
Status:
Completed
Trial end date:
2003-09-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of exatecan mesylate in treating patients
who have metastatic stomach cancer.